Insider buying last 90 days
No open-market insider purchases were filed for ACHC in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every ACHC insider filing, plotted on the chart in Gekko.Open ACHC in Gekko
NASDAQ: ACHC
Acadia Healthcare (ACHC) Stock Analysis & Forecast
Oct 12 close
$30.08+0.83 (+2.8%)
Gekko Brief
AI summaryOct 12 closeThis week's activity around Acadia Healthcare centers on earnings outlook and analyst sentiment. Several notes flagged the company as projected to beat upcoming estimates, continuing a trend of outperformance, while a rating upgrade to Buy reflected improved profit expectations and higher earnings estimates. Cantor Fitzgerald reiterated a Neutral rating with a $30.00 price target, noting that a management-driven shift in job postings skews quarter-over-quarter staffing data but suggests stability. Other commentary pointed to weak sales volumes, declining EPS, and a decreasing ROIC as reasons for caution, even as the stock's six-month return of 13.5% was noted alongside the price crossing above its 200-day moving average.
ACHC closed at $30.08, up 2.8%, sitting above both its 50-day average of $28.98 and 200-day average of $24.61, with the shorter average above the longer one. The GekkoIndex reads 49.8, placing it in the Neutral zone. The current price sits 2.7% below Gekko Fair Value of $30.90.
Earnings are due 4 November 2026, 23 days away, falling inside a typical 20-trading-day holding window; the last report showed EPS of $0.38 against a $0.35 estimate but triggered a 15.8% reaction. Seasonality from this point has averaged a 20-day return of -5.2% over 5 years, rising in 2 of them. No insider, Congress, or unusual options activity appears in the recent windows, though one billionaire holder is recorded. Analyst consensus stands at 7 buy, 3 hold, 1 sell, with a target of $33.79.
Written by AI from the Oct 12, 2026 close and checked automatically against the figures on this page.
Acadia Healthcare price vs fair value
Close $30.08200-day averageGekko Fair Value $30.90
Acadia Healthcare quick facts
- Market cap
- $2.80B
- P/E ratio
- —
- Forward P/E
- 15.2
- EPS, TTM
- −$12.42
- Revenue, TTM
- $3.37B
- Profit margin
- -33.4%
- Dividend yield
- —
- Beta
- 0.63
- Volume
- 1.20M avg 1.49M
- 1-year return
- +19.5%
- Typical daily move
- ±3.7%
- Typical 20-day move
- ±7%
- 50-day average
- $28.98
- 200-day average
- $24.61
- Next earnings
- Nov 4
- Shares outstanding
- 93.10M
Acadia Healthcare swing-trade checklist
Acadia Healthcare scores 1 supportive, 2 mixed and 2 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
1 supportive2 mixed2 headwinds
- Trendsupportive
Above 50 and 200-day
Close $30.08 is above the 50-day ($28.98) and 200-day ($24.61) averages, and the 50-day is above the 200-day.
See the chart - GekkoIndexmixed
49.8, Neutral
Reading 49.8 is in the Neutral zone.
See the GekkoIndex - Fair valuemixed
2.7% below
Price is within 5% of Gekko Fair Value (2.7% below).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings riskheadwind
Reports in 23 days
Reports on Nov 4, 2026, 23 days away — inside a typical 20-trading-day hold.
See earnings - Seasonalityheadwind
−5.2% on average
From this point in the calendar, the next 20 trading days averaged −5.2% over 5 years, rising in 2 of them.
See seasonality
A description of current data, not a recommendation. How this page works
Acadia Healthcare stock chart and price history
Acadia Healthcare closed at $30.08 on Oct 12, 2026, +19.5% over the past year, inside a 52-week range of $11.43 to $35.83.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- +6.1%
- 3 months
- −4.8%
- 6 months
- +13.3%
- 1 year
- +19.5%
The full ACHC chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open ACHC in Gekko
Follow Acadia Healthcare through every session
Put ACHC on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track ACHC in GekkoFree for 7 days. No credit card required.
About Acadia Healthcare
Acadia Healthcare works in the field of mental health and addiction treatment, offering care to patients located throughout the United States as well as Puerto Rico. Its services take several forms, from hospitals that admit patients for acute psychiatric episodes to dedicated treatment centers, residential programs for extended stays, and clinics that see patients on an outpatient basis.
Rather than operating from one location, the company runs a broad collection of facilities that together form its treatment network. By the end of the first quarter of 2022, this network had grown to 238 separate behavioral health sites, offering roughly 10,600 beds in total for patients receiving care.
Founded in 2005, Acadia Healthcare keeps its headquarters in Franklin, Tennessee. Its stock trades on the NASDAQ under the ticker ACHC.
- Listed
- NASDAQ
- Sector
- Health services
- Industry
- Medical/Nursing services
- Website
- acadiahealthcare.com
Acadia Healthcare GekkoIndex: the smart money zone
Acadia Healthcare’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 49.8, in the Neutral zone, down 6.6 points over five sessions.
49.8Neutral
Down 6.6 points over five sessions.
Reading for Oct 12, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 84 | +1.4% | −1.6% | ||
| Accumulation | 296 | −1.1% | −1.4% | ||
| Neutral (current zone) | 279 | −0.3% | −1.7% | ||
| Distribution | 20 | 0.0% | −3.4% | ||
| Selling | 3 | Too few readings yet | |||
Average ACHC share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.1% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
See every daily GekkoIndex reading plotted over the ACHC price, zone by zone.Track ACHC in Gekko
Is Acadia Healthcare stock overvalued? Gekko Fair Value
Acadia Healthcare trades 2.7% below Gekko Fair Value of $30.90, so the shares are about fair value on Gekko’s estimate.
Gekko’s own estimate of what Acadia Healthcare shares are worth, recalculated every trading day.
$30.90
Gekko Fair Value, Oct 10, 2026
2.7% below fair value · About fair value
At the end of Aug 2026 the price was 14.8% below the estimate.
Gekko Fair ValueShare price, month end
Gekko Fair Value on every chart, with the gap to price updating daily.Open ACHC in Gekko
Acadia Healthcare insider and Congress trading
No open-market insider purchases were filed for Acadia Healthcare, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in ACHC were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for ACHC, plotted on the chart in Gekko.Open ACHC in Gekko
Buybacks
Acadia Healthcare has been buying back its own shares.
- Bought back, quarter ended Jun 30, 2026
- $3.81M
- As a share of market cap
- 0.14%
From company filings.
Hedge funds and billionaires quarter ended Jun 30
1of the funds Gekko tracks holds ACHC.
0added0opened1trimmed1sold out
Which funds are on each side, name by name.Unlock in Gekko
Acadia Healthcare earnings: next date and track record
Acadia Healthcare reports on Nov 4, 2026 (23 days away), and beat the EPS estimate in 7 of its last 8 reports.
Next earnings report
Nov 4, 2026
23 days away
- EPS estimate
- $0.46
- Revenue estimate
- $877.8M
7 of 8reports beat the EPS estimate
±15.8%average move across the report
2 of 8reports followed by a gain
Share-price move across each report
Last earnings call, Jul 28, 2026 AI summary
- What they said
- Acadia Healthcare reported Q2 2026 revenue above guidance high end, with adjusted EBITDA of $149.2M near the high end of guidance. Free cash flow reached $124M, enabling $113M in debt reduction. Normalized revenue growth was 2.8% YoY. Two new acute JV facilities opened on schedule in Florida and Iowa. New facility cohorts (2023-2026) delivered revenue and EBITDA ahead of expectations.
- Guidance
- Management expressed confidence in delivering further operational progress in coming quarters with additional free cash flow expected in H2 2026. Primary focus remains operational execution through existing and new facilities, with disciplined capital deployment approach.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Jul 28, 2026 | $0.38 est $0.35 | $865.8M est $844.2M | −15.8% |
| Apr 29, 2026 | $0.37 est $0.26 | $828.8M est $823.5M | −6.1% |
| Feb 25, 2026 | $0.07 est $0.03 | $821.5M est $800.2M | +29.8% |
| Nov 5, 2025 | $0.72 est $0.68 | $851.6M est $848.5M | −1.9% |
| Aug 5, 2025 | $0.83 est $0.71 | $869.2M est $875.5M | −15.8% |
| May 12, 2025 | $0.40 est $0.35 | $770.5M est $769.8M | +13.0% |
| Feb 27, 2025 | $0.64 est $0.75 | $774.2M est $779.0M | −26.9% |
| Oct 30, 2024 | $0.91 est $0.90 | $815.6M est $779.8M | −17.3% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Acadia Healthcare stock forecast and analyst price targets
Analysts’ average 12-month price target for Acadia Healthcare is $33.79, +12.3% from the last close, from 11 firms rating the stock in the last 90 days.
$33.79consensus 12-month target, +12.3% from the last close
Now $30.08Avg $33.79
Low $30High $40
Each firm’s latest rating in the last 90 days: 11 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 28 | Raymond James | $39 | +29.7% |
| Sep 23 | Leerink Partners | $33 | +9.7% |
| Sep 17 | Jefferies | $40 | +33.0% |
| Sep 14 | Bank of America Securities | — | — |
| Aug 28 | Barclays | $32 | +6.4% |
−1.7%average 20-day move after past Neutral readings
−5.2%average move over the next 20 trading days in the last 5 years
±3.7%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Acadia Healthcare seasonality: the next 20 trading days
Over the next 20 trading days from Oct 10, Acadia Healthcare averaged −5.2% across the last 5 years, rising in 2 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +3.6% | 4 of 5 |
| Next 10 trading days | −1.6% | 1 of 5 |
| Next 15 trading days | 0.0% | 3 of 5 |
| Next 20 trading days | −5.2% | 2 of 5 |
| Next 30 trading days | −9.8% | 3 of 5 |
For scale, ACHC’s typical 20-trading-day move in either direction is about 7%.
Acadia Healthcare market cap and key statistics
Acadia Healthcare’s market cap is $2.80B and revenue of $3.37B over the last twelve months.
Valuation
- Market cap
- $2.80B
- Forward P/E
- 15.2
- EPS, TTM
- −$12.42
- Gekko Fair Value
- $30.90
Trading
- Volume
- 1.20M
- Avg volume, 20 days
- 1.49M
- 52-week high
- $35.83
- 52-week low
- $11.43
- Shares outstanding
- 93.10M
Financials
- Revenue, TTM
- $3.37B
- Profit margin
- -33.4%
- Return on equity
- -41.4%
- Quarterly earnings growth, YoY
- −63.6%
Risk and income
- Beta
- 0.63
- Typical daily move
- ±3.7%
- Typical 20-day move
- ±7%
Acadia Healthcare stock news this week
Coverage of Acadia Healthcare this week reads positive: 3 positive, 3 neutral and 1 negative headlines.
- An adviser reports 4.7M Acadia Healthcare (ACHC) shares owned by funds.Stock Titan, Oct 8
- Will Acadia Healthcare (ACHC) Beat Estimates Again in Its Next Earnings Report?Yahoo Finance, Oct 8
- Acadia Healthcare (ACHC): Buy, Sell, or Hold Post Q2 Earnings?TradingView, Oct 7
- Cantor Fitzgerald reiterates Acadia Healthcare stock rating at NeutralInvesting.com India, Oct 6
- How Higher Earnings Estimates Will Impact Acadia Healthcare Stock (ACHC)Simply Wall Street, Oct 6
- Acadia Healthcare (NASDAQ:ACHC) Stock Price Breaks Above 200 Day Moving Average – What’s Next?Defense World, Oct 6
Acadia Healthcare peers
Acadia Healthcare’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| LHLabcorp | Neutral | 2.5% below |
| GHGuardant Health | Accumulation | 10.0% below |
| SOLVSolventum | Accumulation | 20.5% below |
| BTSGBrightSpring Health Services | Neutral | 2.8% above |
| EHCEncompass Health | Neutral | 7.3% above |
| DVADaVita | Neutral | 14.6% below |
A peer links to its own page where one exists.
Acadia Healthcare stock FAQ
What is Acadia Healthcare’s market cap?
Acadia Healthcare’s market cap is $2.80B at the Oct 12, 2026 close of $30.08, with 93.10M shares outstanding.
What is the Acadia Healthcare stock forecast?
The consensus analyst 12-month price target for Acadia Healthcare is $33.79, +12.3% from the last close. Of the 11 firms that rated the stock in the last 90 days, 7 rate it a buy, 3 a hold and 1 a sell. Gekko doesn’t publish price predictions of its own.
Is Acadia Healthcare stock overvalued or undervalued?
On Gekko’s estimate Acadia Healthcare is about fair value: the Oct 12, 2026 close of $30.08 is 2.7% below Gekko Fair Value of $30.90. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does Acadia Healthcare report earnings next?
Acadia Healthcare is expected to report on Nov 4, 2026 (23 days away). Analysts expect earnings of $0.46 per share on revenue of $877.8M. Acadia Healthcare beat the earnings estimate in 7 of its last 8 reports, moving 15.8% on average across the report.
What is Acadia Healthcare’s 52-week high and low?
Acadia Healthcare’s 52-week high is $35.83 and its 52-week low is $11.43; it closed at $30.08 on Oct 12, 2026, +19.5% over the past year. Over the last five years the shares peaked at $89.85 on Nov 30, 2022.
Is Acadia Healthcare stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 1 of the 5 items with data read as supportive (trend), 2 as mixed (gekkoindex and fair value) and 2 as headwinds (earnings risk and seasonality). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Acadia Healthcare the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,408 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.